Keya Joshi

1.2k total citations
20 papers, 185 citations indexed

About

Keya Joshi is a scholar working on Infectious Diseases, Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Keya Joshi has authored 20 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 4 papers in Health and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Keya Joshi's work include SARS-CoV-2 and COVID-19 Research (10 papers), Viral Infections and Immunology Research (4 papers) and COVID-19 epidemiological studies (4 papers). Keya Joshi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Viral Infections and Immunology Research (4 papers) and COVID-19 epidemiological studies (4 papers). Keya Joshi collaborates with scholars based in United States, United Kingdom and Japan. Keya Joshi's co-authors include Rebecca Kahn, Edward Goldstein, Mats Julius Stensrud, Xueting Qiu, Emma K. Accorsi, Müge Çevik, René Niehus, Lee Kennedy‐Shaffer, Marc Lipsitch and Aaron A.R. Tobian and has published in prestigious journals such as The Journal of Physical Chemistry B, Vaccine and European Journal of Epidemiology.

In The Last Decade

Keya Joshi

18 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keya Joshi United States 6 124 80 44 34 19 20 185
Anthony Hauser Switzerland 7 127 1.0× 108 1.4× 47 1.1× 29 0.9× 16 0.8× 15 232
Tanner J. Varrelman United States 6 161 1.3× 70 0.9× 64 1.5× 29 0.9× 16 0.8× 10 241
David Haw United Kingdom 9 119 1.0× 117 1.5× 48 1.1× 23 0.7× 11 0.6× 22 231
Diogo Marques United Kingdom 6 136 1.1× 74 0.9× 89 2.0× 19 0.6× 11 0.6× 9 236
K. Danielle Lecy United States 3 203 1.6× 68 0.8× 38 0.9× 83 2.4× 16 0.8× 4 283
Sara Bressler United States 7 215 1.7× 67 0.8× 65 1.5× 92 2.7× 18 0.9× 13 325
Seonju Yi South Korea 10 183 1.5× 68 0.8× 30 0.7× 62 1.8× 19 1.0× 22 257
Shu Yang China 8 111 0.9× 136 1.7× 51 1.2× 27 0.8× 12 0.6× 17 321
Jacob Curran-Sebastian United Kingdom 4 98 0.8× 73 0.9× 31 0.7× 17 0.5× 7 0.4× 8 170
Hengcong Liu China 6 136 1.1× 142 1.8× 49 1.1× 33 1.0× 7 0.4× 11 249

Countries citing papers authored by Keya Joshi

Since Specialization
Citations

This map shows the geographic impact of Keya Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keya Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keya Joshi more than expected).

Fields of papers citing papers by Keya Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keya Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keya Joshi. The network helps show where Keya Joshi may publish in the future.

Co-authorship network of co-authors of Keya Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Keya Joshi. A scholar is included among the top collaborators of Keya Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keya Joshi. Keya Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshi, Keya, et al.. (2025). Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States. Infectious Diseases and Therapy. 14(6). 1219–1238. 2 indexed citations
2.
Joshi, Keya, et al.. (2025). Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature Review. Journal of Market Access & Health Policy. 13(1). 7–7. 3 indexed citations
3.
Kohli, Michele, et al.. (2025). The potential impact of the next-generation COVID-19 mRNA-1283 vaccine in Canada. Journal of Medical Economics. 28(1). 1440–1450. 2 indexed citations
4.
5.
6.
7.
Kohli, Michele, Michael Maschio, Keya Joshi, et al.. (2024). The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2024 vaccines in the United Kingdom. Journal of Medical Economics. 27(1). 1359–1372. 2 indexed citations
8.
Joshi, Keya, Ekkehard Beck, Michael Maschio, et al.. (2024). The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines. 12(4). 434–434. 1 indexed citations
9.
10.
Davido, Benjamin, Ekkehard Beck, Clarisse Demont, et al.. (2024). Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France. Human Vaccines & Immunotherapeutics. 20(1). 2423474–2423474. 1 indexed citations
11.
Joshi, Keya, Stefan Scholz, Michael Maschio, et al.. (2023). Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany. Journal of Medical Economics. 27(1). 39–50. 9 indexed citations
12.
Kohli, Michele, Michael Maschio, Keya Joshi, et al.. (2023). The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States. Journal of Medical Economics. 26(1). 1532–1545. 16 indexed citations
13.
Joshi, Keya, et al.. (2023). Accelerating Molecular Dynamics Simulations for Drug Discovery. Methods in molecular biology. 2714. 187–202. 2 indexed citations
14.
Joshi, Keya, et al.. (2023). Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics. Vaccine. 41(11). 1864–1874. 2 indexed citations
15.
Joshi, Keya, et al.. (2023). 1635. Assessing the Potential Reduction in Morbidity and Mortality Attainable by Delayed Influenza Vaccine Strain Selection. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
16.
Hung, N., Lane Votapka, Keya Joshi, et al.. (2022). Gaussian Accelerated Molecular Dynamics in OpenMM. The Journal of Physical Chemistry B. 126(31). 5810–5820. 11 indexed citations
17.
Accorsi, Emma K., Xueting Qiu, Lee Kennedy‐Shaffer, et al.. (2021). How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. European Journal of Epidemiology. 36(2). 179–196. 73 indexed citations
18.
Joshi, Keya, Justin Lessler, Oluwasolape Olawore, et al.. (2021). Declining HIV incidence in sub‐Saharan Africa: a systematic review and meta‐analysis of empiric data. Journal of the International AIDS Society. 24(10). e25818–e25818. 34 indexed citations
19.
Dean, Natalie E., Ana Pastore y Piontti, Zachary J. Madewell, et al.. (2020). Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine. 38(46). 7213–7216. 23 indexed citations
20.
Joshi, Keya, Justin Lessler, Oluwasolape Olawore, et al.. (2020). Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data. medRxiv. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony Hauser Breakdown of academic impact, for papers by Tanner J. Varrelman Breakdown of academic impact, for papers by David Haw Breakdown of academic impact, for papers by Diogo Marques Breakdown of academic impact, for papers by K. Danielle Lecy Breakdown of academic impact, for papers by Sara Bressler Breakdown of academic impact, for papers by Seonju Yi Breakdown of academic impact, for papers by Shu Yang Breakdown of academic impact, for papers by Jacob Curran-Sebastian Breakdown of academic impact, for papers by Hengcong Liu
Rankless by CCL
2026